| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.564 | 0.009 | 0.564 | MAP kinase kinase 6 inhibitor | 0.346 0.095 CID_71313317 | ||
| 0.526 | 0.019 | 0.526 | GABA C receptor rho-3 antagonist | |||
| 0.488 | 0.014 | 0.488 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.485 | 0.022 | 0.485 | Nootropic | |||
| 0.475 | 0.016 | 0.475 | Dyrk kinase inhibitor | |||
| 0.448 | 0.01 | 0.448 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.439 | 0.011 | 0.439 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.434 | 0.024 | 0.434 | Tyrosine kinase inhibitor | |||
| 0.448 | 0.044 | 0.448 | Toll-Like receptor agonist | |||
| 0.42 | 0.016 | 0.42 | Clk dual-specificity kinase inhibitor | |||
| 0.425 | 0.025 | 0.425 | Hypoxia-inducible factor 1 alpha inhibitor | 0.252 0.099 CID_71313317 | ||
| 0.401 | 0.017 | 0.401 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.375 | 0.009 | 0.375 | LIM domain kinase 1 inhibitor | |||
| 0.373 | 0.011 | 0.373 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.409 | 0.051 | 0.446 | Angiogenesis inhibitor | 0.446 0.041 CID_71313317 | CID_71313317 | |
| 0.374 | 0.017 | 0.374 | CDC-like kinase 2 inhibitor | |||
| 0.361 | 0.005 | 0.361 | TRKB antagonist | |||
| 0.375 | 0.021 | 0.375 | Death-associated protein kinase 3 inhibitor | |||
| 0.362 | 0.014 | 0.362 | Protein kinase C nu inhibitor | |||
| 0.352 | 0.012 | 0.352 | Lck kinase inhibitor | |||
| 0.358 | 0.023 | 0.358 | RNA-directed DNA polymerase inhibitor | 0.169 0.154 CID_71313317 | ||
| 0.339 | 0.019 | 0.339 | Src kinase inhibitor | |||
| 0.382 | 0.067 | 0.382 | Toll-Like receptor 7 agonist | |||
| 0.331 | 0.025 | 0.331 | CDC-like kinase 4 inhibitor | |||
| 0.312 | 0.011 | 0.312 | Activin receptor-like kinase 2 inhibitor | |||
| 0.306 | 0.005 | 0.306 | ALK inhibitor | |||
| 0.315 | 0.023 | 0.315 | TRKC antagonist | |||
| 0.302 | 0.017 | 0.302 | Protein kinase (CK1) gamma inhibitor | |||
| 0.287 | 0.009 | 0.287 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.364 | 0.093 | 0.364 | Histamine release inhibitor | 0.305 0.121 CID_71313317 | ||
| 0.318 | 0.052 | 0.318 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.302 | 0.041 | 0.47 | Cyclic AMP phosphodiesterase inhibitor | 0.47 0.009 CID_71313317 | CID_71313317 | |
| 0.293 | 0.033 | 0.293 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | |||
| 0.27 | 0.016 | 0.27 | Ribosomal protein S6 kinase inhibitor | |||
| 0.277 | 0.024 | 0.277 | I kappa B kinase epsilon inhibitor | |||
| 0.264 | 0.015 | 0.264 | CDC-like kinase 1 inhibitor | |||
| 0.279 | 0.033 | 0.279 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.257 | 0.012 | 0.257 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | |||
| 0.245 | 0.005 | 0.245 | Folate antagonist | 0.11 0.049 CID_71313317 | ||
| 0.276 | 0.044 | 0.276 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.248 | 0.018 | 0.248 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | |||
| 0.248 | 0.018 | 0.248 | Abl kinase inhibitor | |||
| 0.26 | 0.032 | 0.26 | Focal adhesion kinase 2 inhibitor | |||
| 0.249 | 0.027 | 0.249 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.236 | 0.017 | 0.236 | MAP kinase 9 inhibitor | |||
| 0.239 | 0.023 | 0.239 | Protein kinase (CK1) gamma 2 inhibitor | |||
| 0.223 | 0.007 | 0.223 | Macrophage colony-stimulating factor 1 receptor antagonist | |||
| 0.225 | 0.01 | 0.225 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.157 0.061 CID_71313317 | ||
| 0.244 | 0.033 | 0.244 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.228 | 0.026 | 0.228 | Toll-Like receptor 9 antagonist | |||
| 0.232 | 0.035 | 0.232 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.227 | 0.032 | 0.227 | Polo-like kinase-3 inhibitor | |||
| 0.203 | 0.008 | 0.203 | DNA repair enzyme inhibitor | 0.158 0.025 CID_71313317 | ||
| 0.202 | 0.009 | 0.202 | Platelet growth factor antagonist | |||
| 0.347 | 0.154 | 0.347 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.223 | 0.033 | 0.223 | Tyrosine-protein kinase receptor antagonist | |||
| 0.223 | 0.034 | 0.223 | Vascular endothelial growth factor 3 antagonist | |||
| 0.203 | 0.013 | 0.203 | Protein kinase C gamma inhibitor | |||
| 0.196 | 0.006 | 0.196 | Toll-Like receptor 3 antagonist | |||
| 0.2 | 0.014 | 0.2 | Activin receptor-like kinase 4 inhibitor | |||
| 0.248 | 0.062 | 0.248 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.214 | 0.028 | 0.214 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.241 | 0.058 | 0.241 | MAP kinase kinase 2 inhibitor | |||
| 0.217 | 0.035 | 0.217 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.207 | 0.027 | 0.207 | Protein kinase (CK1) delta inhibitor | |||
| 0.195 | 0.016 | 0.195 | MAP kinase kinase 4 inhibitor | 0.134 0.103 CID_71313317 | ||
| 0.192 | 0.013 | 0.192 | Protein kinase C mu inhibitor | 0.087 0.071 CID_71313317 | ||
| 0.196 | 0.018 | 0.196 | Beta amyloid protein antagonist | 0.105 0.083 CID_71313317 | ||
| 0.239 | 0.063 | 0.239 | EphB2 antagonist | |||
| 0.208 | 0.035 | 0.208 | Cyclin-dependent kinase inhibitor | |||
| 0.229 | 0.058 | 0.229 | MAP kinase kinase 3 inhibitor | |||
| 0.2 | 0.03 | 0.2 | TRKA antagonist | |||
| 0.179 | 0.015 | 0.179 | Raf kinase inhibitor | |||
| 0.242 | 0.077 | 0.242 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.239 | 0.074 | 0.41 | DNA synthesis inhibitor | 0.41 0.02 CID_71313317 | CID_71313317 | |
| 0.172 | 0.008 | 0.172 | mTOR complex 1 inhibitor | |||
| 0.204 | 0.041 | 0.204 | RET inhibitor | |||
| 0.166 | 0.007 | 0.166 | mTOR complex 2 inhibitor | |||
| 0.206 | 0.048 | 0.206 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.195 | 0.041 | 0.195 | Protein kinase (CK1) inhibitor | |||
| 0.176 | 0.023 | 0.176 | Polo-like kinase-4 inhibitor | |||
| 0.181 | 0.03 | 0.181 | Cyclin-dependent kinase 1 inhibitor | |||
| 0.175 | 0.023 | 0.175 | Fibroblast growth factor 1 antagonist | |||
| 0.189 | 0.039 | 0.189 | c-Src kinase inhibitor | |||
| 0.205 | 0.055 | 0.205 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.166 | 0.016 | 0.166 | Protein kinase C zeta inhibitor | |||
| 0.187 | 0.037 | 0.187 | GABA C receptor rho-2 antagonist | |||
| 0.191 | 0.044 | 0.191 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.311 | 0.168 | 0.311 | MAP kinase 1 inhibitor | |||
| 0.172 | 0.031 | 0.172 | Aurora-C kinase inhibitor | |||
| 0.156 | 0.017 | 0.156 | CDC-like kinase 3 inhibitor | 0.097 0.085 CID_71313317 | ||
| 0.185 | 0.046 | 0.185 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.16 | 0.021 | 0.16 | TIE antagonist | |||
| 0.167 | 0.029 | 0.167 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.156 | 0.019 | 0.156 | Phosphodiesterase 7B inhibitor | |||
| 0.15 | 0.017 | 0.15 | Adenosine A2 receptor antagonist | |||
| 0.171 | 0.039 | 0.171 | Aurora-B kinase inhibitor | |||
| 0.146 | 0.018 | 0.146 | AXL receptor tyrosine kinase inhibitor | |||
| 0.322 | 0.195 | 0.546 | Antiinflammatory | 0.546 0.07 CID_71313317 | CID_71313317 | |
| 0.138 | 0.015 | 0.138 | Cyclin A2 inhibitor | |||
| 0.197 | 0.074 | 0.197 | Histone acetyltransferase inhibitor | |||
| 0.199 | 0.078 | 0.199 | Neurotrophic factor enhancer | |||
| 0.137 | 0.017 | 0.137 | Raf kinase C inhibitor | |||
| 0.132 | 0.013 | 0.132 | CDC7 inhibitor | |||
| 0.136 | 0.017 | 0.136 | Adenosine A2a receptor antagonist | |||
| 0.138 | 0.02 | 0.138 | Phosphodiesterase I inhibitor | |||
| 0.126 | 0.009 | 0.126 | Secretase beta inhibitor | |||
| 0.138 | 0.021 | 0.138 | Janus tyrosine kinase 3 inhibitor | |||
| 0.129 | 0.013 | 0.129 | Phosphodiesterase III inhibitor | |||
| 0.132 | 0.016 | 0.132 | Raf kinase B inhibitor | |||
| 0.164 | 0.05 | 0.164 | Phosphodiesterase inhibitor | |||
| 0.127 | 0.013 | 0.127 | I kappa B kinase 1 inhibitor | |||
| 0.12 | 0.01 | 0.12 | Polo-like kinase-2 inhibitor | |||
| 0.134 | 0.026 | 0.134 | TIE-2 antagonist | |||
| 0.148 | 0.04 | 0.148 | Aurora-A kinase inhibitor | |||
| 0.166 | 0.06 | 0.166 | Growth factor antagonist | |||
| 0.139 | 0.034 | 0.139 | MAP kinase 8 inhibitor | |||
| 0.121 | 0.016 | 0.121 | Phosphatidylinositol kinase inhibitor | |||
| 0.156 | 0.052 | 0.156 | Toll-Like receptor antagonist | |||
| 0.126 | 0.022 | 0.126 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.103 0.036 CID_71313317 | ||
| 0.122 | 0.019 | 0.122 | Adenosine A1 receptor antagonist | 0.061 0.038 CID_71313317 | ||
| 0.115 | 0.012 | 0.115 | Transforming growth factor beta 3 antagonist | |||
| 0.12 | 0.017 | 0.12 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.112 | 0.01 | 0.112 | mTOR inhibitor | |||
| 0.119 | 0.017 | 0.119 | Cyclin A inhibitor | |||
| 0.109 | 0.009 | 0.109 | Phosphodiesterase 3B inhibitor | |||
| 0.126 | 0.026 | 0.126 | Janus tyrosine kinase 2 inhibitor | |||
| 0.11 | 0.011 | 0.11 | Bromodomain-containing protein 4 inhibitor | |||
| 0.121 | 0.022 | 0.121 | Glutamate release inhibitor | |||
| 0.113 | 0.014 | 0.113 | Phosphatidylinositol 3-kinase alpha inhibitor | |||
| 0.156 | 0.058 | 0.156 | MAP kinase 3 inhibitor | |||
| 0.168 | 0.071 | 0.168 | Heat shock protein 90 alpha antagonist | |||
| 0.139 | 0.042 | 0.139 | Interleukin 8 antagonist | |||
| 0.229 | 0.133 | 0.229 | Immunomodulator | 0.213 0.148 CID_71313317 | ||
| 0.127 | 0.031 | 0.127 | Electrolyte absorption antagonist | |||
| 0.138 | 0.043 | 0.138 | Cyclin-dependent kinase 2 inhibitor | |||
| 0.107 | 0.013 | 0.107 | 5 Hydroxytryptamine 3 agonist | |||
| 0.118 | 0.024 | 0.118 | Fibroblast growth factor 3 antagonist | |||
| 0.128 | 0.035 | 0.128 | Interleukin 2 antagonist | 0.106 0.073 CID_71313317 | ||
| 0.153 | 0.06 | 0.153 | Cytokine production inhibitor | |||
| 0.136 | 0.044 | 0.136 | 5 Hydroxytryptamine 3A agonist | |||
| 0.148 | 0.056 | 0.148 | Nav1.6 sodium channel blocker | |||
| 0.182 | 0.092 | 0.182 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.15 | 0.06 | 0.15 | Cyclin-dependent kinase 7 inhibitor | |||
| 0.127 | 0.037 | 0.127 | CDK2/cyclin A inhibitor | |||
| 0.127 | 0.038 | 0.127 | Insulin receptor antagonist | |||
| 0.127 | 0.038 | 0.127 | CDK/cyclin complex inhibitor | |||
| 0.107 | 0.018 | 0.107 | MAP3K7 inhibitor | |||
| 0.11 | 0.023 | 0.11 | Focal adhesion kinase 1 inhibitor | |||
| 0.123 | 0.036 | 0.123 | Nitric-oxide synthase inhibitor | |||
| 0.098 | 0.011 | 0.098 | Phosphodiesterase 1C inhibitor | |||
| 0.111 | 0.025 | 0.111 | HIV-1 reverse transcriptase inhibitor | |||
| 0.112 | 0.029 | 0.112 | Bromodomain-containing protein 2 inhibitor | |||
| 0.107 | 0.025 | 0.107 | Tyk2 inhibitor | |||
| 0.153 | 0.071 | 0.153 | Heat shock protein 90 antagonist | |||
| 0.139 | 0.058 | 0.139 | Tyrosine-protein kinase receptor FLT3 inhibitor | |||
| 0.101 | 0.019 | 0.101 | Phosphodiesterase VI inhibitor | |||
| 0.094 | 0.013 | 0.094 | Phosphodiesterase II inhibitor | |||
| 0.133 | 0.053 | 0.133 | Protein kinase (CK2) alpha inhibitor | |||
| 0.093 | 0.013 | 0.093 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.161 | 0.082 | 0.161 | Antipruritic | |||
| 0.082 | 0.005 | 0.082 | Dihydrofolate reductase inhibitor | |||
| 0.111 | 0.036 | 0.111 | Pim-3 kinase inhibitor | |||
| 0.082 | 0.008 | 0.082 | Histamine H4 receptor antagonist | |||
| 0.098 | 0.025 | 0.098 | CDK1/cyclin B inhibitor | |||
| 0.099 | 0.026 | 0.099 | Protein kinase B beta inhibitor | |||
| 0.121 | 0.05 | 0.121 | Platelet activating factor beta antagonist | |||
| 0.084 | 0.012 | 0.084 | Phosphodiesterase 2A inhibitor | |||
| 0.186 | 0.116 | 0.186 | Nitric-oxide synthase stimulant | |||
| 0.087 | 0.017 | 0.087 | Cyclin B1 inhibitor | |||
| 0.096 | 0.027 | 0.096 | Cyclin-dependent kinase 4 inhibitor | |||
| 0.104 | 0.036 | 0.104 | MAP-kinase-activated kinase inhibitor | |||
| 0.103 | 0.035 | 0.103 | CYP2A6 inhibitor | |||
| 0.095 | 0.028 | 0.095 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.117 | 0.051 | 0.117 | Check point kinase 2 inhibitor | |||
| 0.086 | 0.021 | 0.086 | Glutamate (mGluR7) antagonist | |||
| 0.121 | 0.058 | 0.121 | Transcription factor STAT6 inhibitor | |||
| 0.099 | 0.036 | 0.099 | Myeloperoxidase inhibitor | |||
| 0.095 | 0.033 | 0.095 | Protein kinase B alpha inhibitor | |||
| 0.11 | 0.049 | 0.11 | GABA C receptor rho-1 antagonist | |||
| 0.087 | 0.026 | 0.087 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.089 | 0.029 | 0.089 | Fibroblast growth factor 2 antagonist | |||
| 0.099 | 0.04 | 0.099 | I kappa B kinase inhibitor | |||
| 0.088 | 0.029 | 0.088 | MAP kinase kinase 7 inhibitor | |||
| 0.076 | 0.017 | 0.076 | Cyclin B2 inhibitor | |||
| 0.071 | 0.013 | 0.071 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.102 | 0.044 | 0.102 | Protein kinase A inhibitor | |||
| 0.083 | 0.024 | 0.083 | Phosphatidylinositol 3-kinase delta inhibitor | |||
| 0.076 | 0.019 | 0.076 | Phosphodiesterase 1A inhibitor | |||
| 0.101 | 0.044 | 0.101 | Polo-like kinase-1 inhibitor | |||
| 0.075 | 0.018 | 0.075 | Cyclin B inhibitor | |||
| 0.125 | 0.069 | 0.125 | MAP kinase kinase inhibitor | |||
| 0.075 | 0.02 | 0.075 | Toll-Like receptor 8 antagonist | |||
| 0.097 | 0.044 | 0.097 | Bcr-Abl kinase inhibitor | |||
| 0.076 | 0.022 | 0.076 | Bruton tyrosine kinase inhibitor | |||
| 0.075 | 0.023 | 0.075 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.101 | 0.05 | 0.101 | Hepatocyte growth factor antagonist | |||
| 0.086 | 0.038 | 0.086 | MAP-kinase-activated kinase 2 inhibitor | |||
| 0.1 | 0.053 | 0.1 | Protein kinase C delta inhibitor | |||
| 0.068 | 0.021 | 0.068 | Histamine agonist | |||
| 0.058 | 0.012 | 0.058 | Alpha 1d adrenoreceptor agonist | |||
| 0.134 | 0.088 | 0.134 | Peroxidase inhibitor | |||
| 0.105 | 0.059 | 0.105 | Protein kinase (CK2) inhibitor | |||
| 0.058 | 0.013 | 0.058 | Glutamate (mGluR group II) agonist | |||
| 0.113 | 0.068 | 0.113 | Glycogen synthase kinase-3 inhibitor | |||
| 0.11 | 0.066 | 0.11 | Cyclin-dependent kinase 5 inhibitor | |||
| 0.066 | 0.023 | 0.066 | Proto-oncogene tyrosine-protein kinase Met inhibitor | |||
| 0.054 | 0.012 | 0.054 | Glutamate (mGluR2) agonist | |||
| 0.063 | 0.022 | 0.063 | Adenosine A2b receptor antagonist | |||
| 0.056 | 0.016 | 0.056 | Guanylate cyclase stimulant | |||
| 0.089 | 0.05 | 0.089 | Leucine-rich repeat kinase 2 inhibitor | |||
| 0.079 | 0.041 | 0.079 | Phosphodiesterase 5A inhibitor | |||
| 0.066 | 0.027 | 0.066 | Phosphatidylinositol 3-kinase gamma inhibitor | |||
| 0.048 | 0.011 | 0.048 | Potassium channel small-conductance Ca-activated activator | |||
| 0.079 | 0.042 | 0.079 | Phosphodiesterase V inhibitor | |||
| 0.072 | 0.035 | 0.072 | Glutamate (mGluR) agonist | |||
| 0.09 | 0.054 | 0.09 | Insulin growth factor antagonist | |||
| 0.055 | 0.019 | 0.055 | Cytokine production stimulant | |||
| 0.08 | 0.046 | 0.08 | Rho-associated kinase inhibitor | |||
| 0.065 | 0.032 | 0.065 | CDK4/cyclin D inhibitor | |||
| 0.053 | 0.02 | 0.053 | Cyclin D3 inhibitor | |||
| 0.109 | 0.076 | 0.109 | Vascular endothelial growth factor antagonist | |||
| 0.041 | 0.008 | 0.041 | DNA topoisomerase IV inhibitor | |||
| 0.074 | 0.042 | 0.074 | Transforming growth factor antagonist | |||
| 0.058 | 0.026 | 0.058 | Phosphatidylinositol 3-kinase beta inhibitor | |||
| 0.078 | 0.046 | 0.078 | Adenosine A3 receptor antagonist | |||
| 0.063 | 0.032 | 0.063 | Phosphodiesterase 4C inhibitor | |||
| 0.043 | 0.011 | 0.043 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.073 | 0.041 | 0.073 | MAP kinase kinase 8 inhibitor | |||
| 0.085 | 0.054 | 0.085 | Insulin like growth factor 1 antagonist | |||
| 0.056 | 0.025 | 0.056 | Nicotinic receptor alpha4 subunit antagonist | |||
| 0.109 | 0.078 | 0.16 | DNA polymerase I inhibitor | 0.16 0.044 CID_71313317 | CID_71313317 | |
| 0.159 | 0.128 | 0.159 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.16 | 0.13 | 0.16 | Aldehyde oxidase inhibitor | |||
| 0.213 | 0.183 | 0.378 | Immunosuppressant | 0.378 0.073 CID_71313317 | CID_71313317 | |
| 0.075 | 0.045 | 0.075 | Syk tyrosine kinase inhibitor | |||
| 0.086 | 0.056 | 0.086 | Phosphodiesterase IV inhibitor | |||
| 0.065 | 0.035 | 0.065 | Xanthine dehydrogenase inhibitor | |||
| 0.039 | 0.01 | 0.039 | CDK4/cyclin D3 inhibitor | |||
| 0.064 | 0.035 | 0.064 | Tyrosine-protein kinase EMT inhibitor | |||
| 0.033 | 0.005 | 0.033 | Phosphodiesterase 6A inhibitor | |||
| 0.064 | 0.036 | 0.064 | Janus tyrosine kinase 1 inhibitor | |||
| 0.088 | 0.06 | 0.088 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | |||
| 0.059 | 0.032 | 0.059 | NMDA 2B receptor antagonist | |||
| 0.058 | 0.031 | 0.058 | Lysine-specific demethylase 1A inhibitor | |||
| 0.072 | 0.045 | 0.072 | CDK1/cyclin B1 inhibitor | |||
| 0.064 | 0.037 | 0.064 | Cyclin D1 inhibitor | |||
| 0.092 | 0.066 | 0.092 | DNA directed RNA polymerase inhibitor | |||
| 0.051 | 0.026 | 0.051 | Thymidylate synthase inhibitor | |||
| 0.071 | 0.046 | 0.071 | Toll-Like receptor 7 antagonist | |||
| 0.095 | 0.071 | 0.095 | MAP kinase kinase kinase inhibitor | |||
| 0.169 | 0.146 | 0.169 | DNA damaging | |||
| 0.1 | 0.077 | 0.1 | GABA receptor agonist | |||
| 0.04 | 0.017 | 0.04 | ATM kinase inhibitor | |||
| 0.061 | 0.04 | 0.061 | Phosphodiesterase 1B inhibitor | |||
| 0.068 | 0.047 | 0.068 | Purinergic P2X2 antagonist | |||
| 0.046 | 0.026 | 0.046 | Histamine H1 receptor agonist | |||
| 0.04 | 0.02 | 0.04 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.076 | 0.057 | 0.076 | Glutamate receptor agonist | |||
| 0.082 | 0.063 | 0.082 | D-Ala-D-Ala ligase inhibitor | |||
| 0.052 | 0.033 | 0.052 | Transforming growth factor beta 1 antagonist | |||
| 0.098 | 0.08 | 0.098 | Glycogen synthase kinase-3 beta inhibitor | |||
| 0.098 | 0.08 | 0.098 | Platelet activating factor antagonist | |||
| 0.08 | 0.062 | 0.08 | Inducible nitric-oxide synthase inhibitor | |||
| 0.022 | 0.005 | 0.022 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.016 0.014 CID_71313317 | ||
| 0.073 | 0.056 | 0.073 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | |||
| 0.024 | 0.007 | 0.024 | Toll-Like receptor 8 agonist | |||
| 0.075 | 0.059 | 0.075 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | |||
| 0.057 | 0.041 | 0.057 | CDK4/cyclin D1 inhibitor | |||
| 0.086 | 0.07 | 0.086 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.026 | 0.012 | 0.044 | Adenosine kinase inhibitor | 0.044 0.006 CID_71313317 | CID_71313317 | |
| 0.021 | 0.007 | 0.021 | Granulocyte colony stimulating factor receptor agonist | |||
| 0.058 | 0.044 | 0.058 | Cyclin A1 inhibitor | |||
| 0.073 | 0.06 | 0.073 | MAP kinase 10 inhibitor | |||
| 0.022 | 0.009 | 0.022 | Alpha 2c adrenoreceptor agonist | |||
| 0.055 | 0.043 | 0.055 | EphB4 antagonist | |||
| 0.034 | 0.022 | 0.034 | CDK6/cyclin D3 inhibitor | |||
| 0.038 | 0.026 | 0.038 | Diamine oxidase inhibitor | |||
| 0.022 | 0.01 | 0.022 | Histamine H4 receptor agonist | |||
| 0.043 | 0.032 | 0.043 | AICAR transformylase inhibitor | |||
| 0.092 | 0.08 | 0.092 | Ferrochelatase inhibitor | |||
| 0.082 | 0.071 | 0.082 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.097 | 0.086 | 0.097 | MAP kinase 13 inhibitor | |||
| 0.033 | 0.023 | 0.033 | Protein kinase (CK2) beta inhibitor | |||
| 0.129 | 0.119 | 0.129 | CF transmembrane conductance regulator agonist | |||
| 0.061 | 0.051 | 0.061 | Aryl hydrocarbon receptor antagonist | |||
| 0.078 | 0.068 | 0.078 | GABA A receptor agonist | |||
| 0.063 | 0.053 | 0.063 | Cyclin B3 inhibitor | |||
| 0.062 | 0.052 | 0.062 | Neuronal nicotinic receptor antagonist | |||
| 0.028 | 0.019 | 0.028 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.081 | 0.072 | 0.081 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | |||
| 0.031 | 0.022 | 0.031 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.089 | 0.08 | 0.089 | Vascular endothelial growth factor 2 antagonist | |||
| 0.062 | 0.055 | 0.062 | Check point kinase 1 inhibitor | |||
| 0.067 | 0.06 | 0.067 | Rho-associated kinase I inhibitor | |||
| 0.029 | 0.023 | 0.029 | Plasmepsin I inhibitor | |||
| 0.043 | 0.037 | 0.043 | Adenosine deaminase inhibitor | |||
| 0.04 | 0.035 | 0.04 | Nerve growth factor antagonist | |||
| 0.031 | 0.026 | 0.031 | ATR kinase inhibitor | |||
| 0.037 | 0.032 | 0.037 | Protein kinase (CK1) epsilon inhibitor | |||
| 0.041 | 0.036 | 0.041 | Glutamate (mGluR group III) antagonist | |||
| 0.051 | 0.047 | 0.051 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.063 | 0.062 | 0.063 | Protein kinase C beta inhibitor | |||
| 0.056 | 0.055 | 0.056 | I kappa B kinase 2 inhibitor | |||
| 0.036 | 0.035 | 0.036 | CDK5/p25 inhibitor | |||
| 0.013 | 0.012 | 0.013 | 5 Lipoxygenase activating protein inhibitor | |||
| 0.032 | 0.056 | 0.044 | Antimetabolite | 0.044 0.036 CID_71313317 | CID_71313317 | |
| 0.076 | 0.127 | 0.192 | Alkylator | 0.192 0.029 CID_71313317 | CID_71313317 | |
| 0.071 | 0.123 | 0.099 | DNA intercalator | 0.099 0.075 CID_71313317 | CID_71313317 | |
| 0.181 | 0.254 | 0.494 | Antibacterial | 0.494 0.042 CID_71313317 | CID_71313317 | |
| 0.03 | 0.116 | 0.067 | Factor IXa inhibitor | 0.067 0.022 CID_71313317 | CID_71313317 | |
| 0.056 | 0.155 | 0.125 | Topoisomerase II inhibitor | 0.125 0.063 CID_71313317 | CID_71313317 | |
| 0.066 | 0.246 | 0.119 | Diuretic | 0.119 0.106 CID_71313317 | CID_71313317 | |
| 0.024 | 0.212 | 0.06 | Heparanase inhibitor | 0.06 0.022 CID_71313317 | CID_71313317 | |
| 0.025 | 0.277 | 0.144 | Topoisomerase I inhibitor | 0.144 0.043 CID_71313317 | CID_71313317 | |
| 0.091 | 0.384 | 0.135 | CC chemokine 6 receptor antagonist | 0.135 0.055 CID_71313317 | CID_71313317 | |
| 0.042 | 0.38 | 0.27 | Immunostimulant | 0.27 0.089 CID_71313317 | CID_71313317 | |
| 0.088 | 0.525 | 0.263 | Peptidyltransferase inhibitor | 0.263 0.042 CID_71313317 | CID_71313317 | |
| 0.019 | 0.512 | 0.123 | Thrombolytic | 0.123 0.107 CID_71313317 | CID_71313317 | |
| 0.082 | 0.578 | 0.219 | Interleukin 2 agonist | 0.219 0.158 CID_71313317 | CID_71313317 | |
| 0.051 | 0.633 | 0.517 | Cyclophilin D inhibitor | 0.517 0.045 CID_71313317 | CID_71313317 | |
| 0.01 | 0.605 | 0.035 | Antibiotic Aminoglycoside-like | 0.035 0.027 CID_71313317 | CID_71313317 | |
| 0.032 | 0.659 | 0.168 | Hepatoprotectant | 0.168 0.091 CID_71313317 | CID_71313317 | |
| 0.043 | 0.734 | 0.163 | Catenin beta inhibitor | 0.163 0.078 CID_71313317 | CID_71313317 | |
| 0.008 | 0.713 | 0.142 | Lipid peroxidase inhibitor | 0.142 0.074 CID_71313317 | CID_71313317 | |
| 0.029 | 0.749 | 0.247 | Apoptosis agonist | 0.247 0.218 CID_71313317 | CID_71313317 | |
| 0.003 | 0.733 | 0.091 | Antineoplastic antibiotic | 0.091 0.05 CID_71313317 | CID_71313317 | |
| 0.011 | 0.762 | 0.258 | Angiogenesis stimulant | 0.258 0.066 CID_71313317 | CID_71313317 | |
| 0.004 | 0.828 | 0.12 | Selectin antagonist | 0.12 0.022 CID_71313317 | CID_71313317 | |
| 0.004 | 0.941 | 0.16 | Antioxidant | 0.16 0.154 CID_71313317 | CID_71313317 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |